Probiotec Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Probiotec Limited with three other
pharmaceutical manufacturers in Australasia:
Vita Life Sciences Limited.
(2017
sales of 37.74 million Australian Dollars [US$29.37 million]
),
Acrux Ltd
(23.93 million Australian Dollars [US$18.63 million]
of which 100%
was Pharmaceutical Research and Development), and
AFT Pharmaceuticals Ltd
which is
based in New Zealand
(69.21 million New Zealand Dollars [US$50.96 million]
of which 100%
was Pharmaceutical).
Sales Analysis.
Probiotec Limited reported sales of A$62.55 million (US$48.67 million)
for the
fiscal
year ending
June of 2017.
This
represents
a
decrease of 4.7%
versus 2016, when the company's sales were A$65.61 million.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Probiotec Limited had sales
of A$66.05 million.